|
|
|
|
| LEADER |
00000cam a22000002cc4500 |
| 001 |
1101869143 |
| 003 |
DE-627 |
| 005 |
20230426130358.0 |
| 007 |
tu |
| 008 |
930212s1991 xx ||||| 00| ||eng c |
| 024 |
8 |
|
|a Serial no. J-101-41
|q Sonstige Nr.
|
| 035 |
|
|
|a (DE-627)1101869143
|
| 035 |
|
|
|a (DE-576)031869149
|
| 035 |
|
|
|a (DE-599)BSZ031869149
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
0 |
0 |
|a Review of the national drug control strategy
|n 2
|p 101st Congress, 1. session on the oversight of the President's national drug control strategy, October 3, 1989
|
| 264 |
|
1 |
|a Washington, DC
|b U.S. GPO
|c 1991
|
| 300 |
|
|
|a III, 134 S. (S. hrg.
|c 101-834, Pt. 2)
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a S. hrg.
|v 101-834, Pt. 2
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 773 |
1 |
8 |
|a Review of the national drug control strategy hearing before the Committee on the Judiciary, United States Senate
|w (DE-627)1101868503
|w (DE-576)031868509
|g 2
|q 2
|7 nnam
|
| 810 |
2 |
|
|a USA
|b Congress
|b Senate
|t Senate hearing
|v 101-834, Pt. 2
|9 101-834, Pt. 2
|w (DE-627)1083362127
|w (DE-576)013362127
|7 am
|
| 935 |
|
|
|a mkri
|
| 951 |
|
|
|a MV
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 2201030596
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1101869143
|
| LOK |
|
|
|0 005 19930212000000
|
| LOK |
|
|
|0 008 930212||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-Frei85
|c DE-627
|d DE-Frei85
|
| LOK |
|
|
|0 852
|a DE-Frei85
|
| LOK |
|
|
|0 852 1
|m p
|9 00
|
| LOK |
|
|
|0 938
|k p
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
